<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04938804</url>
  </required_header>
  <id_info>
    <org_study_id>GZLUNG</org_study_id>
    <nct_id>NCT04938804</nct_id>
  </id_info>
  <brief_title>Mass Screening With Low-Dose CT for Lung Cancer in Guangzhou</brief_title>
  <official_title>Mass Screening With Low-Dose CT for Lung Cancer in Guangzhou</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Guangzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Guangzhou Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single-arm, prospective study to explore the incidence of lung cancer, the high-risk factor&#xD;
      of lung cancer, and the cost-effectiveness of early screening of lung cancer in the general&#xD;
      population over 40 years old with low-dose computed tomography in Guangzhou, China&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2015</start_date>
  <completion_date type="Anticipated">December 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of lung cancer</measure>
    <time_frame>11 years</time_frame>
    <description>The incidence of lung cancer among the overall people in the screening</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of lung cancer among people with high-risk factors</measure>
    <time_frame>11 years</time_frame>
    <description>The incidence of lung cancer among people with high-risk factors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of lung cancer among people with non-high-risk factors</measure>
    <time_frame>11 years</time_frame>
    <description>The incidence of lung cancer among people with non-high-risk factors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High risk factors associated with lung cancer (by questionnaire)</measure>
    <time_frame>11 years</time_frame>
    <description>Every participant has to complete a questionnaire before undergoing an LDCT examination. Univariate analysis and multivariate logistic regression analyses will be performed to determine the high risk factors associated with lung cancer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness ratio (costs of examinations, diagnoses, and treatments)</measure>
    <time_frame>11 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">11000</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Screening group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low-dose computed tomography</intervention_name>
    <description>The Low-dose computed tomography is conducted according to the guideline suggested by American College of Radiology.</description>
    <arm_group_label>Screening group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Minimum age of 40 years among the residents in Guangzhou&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Persons who had a diagnosis of lung cancer or treatment-related to lung cancer with&#xD;
             the past 5 years, had a diagnosis of any other cancer within the past 5 years (except&#xD;
             for nonmelanoma skin cancer)&#xD;
&#xD;
          -  Had hemoptysis&#xD;
&#xD;
          -  Had an unexplained weight loss of more than 6.8 kg in the previous year&#xD;
&#xD;
          -  Had a CT scan of chest within the previous year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wenhua Liang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital of Guangzhou Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wenhua Liang, MD</last_name>
    <phone>+86-02-83062808</phone>
    <email>liangwh1987@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenhua Liang, MD</last_name>
      <phone>+86-02-83062808</phone>
      <email>liangwh1987@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 12, 2021</study_first_submitted>
  <study_first_submitted_qc>June 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 24, 2021</study_first_posted>
  <last_update_submitted>June 23, 2021</last_update_submitted>
  <last_update_submitted_qc>June 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Guangzhou Medical University</investigator_affiliation>
    <investigator_full_name>Jianxing He</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

